Alexandre Akoulitchev
Founder at OXFORD BIODYNAMICS PLC
Net worth: 784 116 $ as of 2024-03-30
Profile
Alexandre Akoulitchev is the founder of Oxford BioDynamics Plc, which was founded in 2007.
He held the title of Executive Director & Chief Scientific Officer at the company.
Dr. Akoulitchev is currently a Non-Executive Director at Sibelius Ltd.
and a Director at Wittgenstean Associates Ltd.
Dr. Akoulitchev previously worked as a Director at Chronos Therapeutics Ltd.
Dr. Akoulitchev has a graduate degree from the University of Oxford and a doctorate degree from University College London.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
OXFORD BIODYNAMICS PLC
3.26% | 2024-04-04 | 6,603,082 ( 3.26% ) | 784 116 $ | 2024-03-30 |
Alexandre Akoulitchev active positions
Companies | Position | Start |
---|---|---|
OXFORD BIODYNAMICS PLC | Founder | 2007-04-22 |
Sibelius Ltd. | Director/Board Member | - |
Wittgenstean Associates Ltd. | Director/Board Member | - |
Former positions of Alexandre Akoulitchev
Companies | Position | End |
---|---|---|
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
Training of Alexandre Akoulitchev
University of Oxford | Graduate Degree |
University College London | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
OXFORD BIODYNAMICS PLC | Health Technology |
Private companies | 3 |
---|---|
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Sibelius Ltd. | |
Wittgenstean Associates Ltd. |
- Stock Market
- Insiders
- Alexandre Akoulitchev